Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 16, 2023, titled "Zydus receives approval from USFDA to initiate Phase II clinical trial of ZYIL1 in patients with Parkinson s disease".
Press Release Dec 16 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Dec 15 2023
- Press Release Dec 14 2023
- Press Release Dec 11 2023
- Press Release Dec 06 2023
- Press Release Dec 01 2023
Later from Zydus Lifesciences
- Press Release Dec 22 2023
- Press Release Jan 17 2024
- Zydus Lifesciences Limited Press Release Jan 19 2024
- Press Release Jan 25 2024
- Zydus Lifesciences Limited Press Release Jan 30 2024
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences